EP Patent

EP3143986A1 — Hydrophilic gel for topical delivery of 5-aminolevulinic acid and production thereof

Assigned to Zimmer MedizinSysteme GmbH · Expires 2017-03-22 · 9y expired

What this patent protects

The present invention relates to a pharmaceutical topical gel solution that contains 5-aminolevulinic acid (5-ALA) and an aqueous low viscous gel matrix. This invention also relates to a pharmaceutical preparation containing this composition. The formulation of this type can be u…

USPTO Abstract

The present invention relates to a pharmaceutical topical gel solution that contains 5-aminolevulinic acid (5-ALA) and an aqueous low viscous gel matrix. This invention also relates to a pharmaceutical preparation containing this composition. The formulation of this type can be used in photodynamic therapy as well as in the photodynamic detection of abnormally proliferating cells.

Drugs covered by this patent

aminolevulinic-acid-hydrochloride (AMINOLEVULINIC ACID HYDROCHLORIDE)

Patent Metadata

Patent number: EP3143986A1
Jurisdiction: EP
Classification: —
Expires: 2017-03-22
Drug substance claim: No
Drug product claim: No
Assignee: Zimmer MedizinSysteme GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.